This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n16http://localhost/temp/predkladatel/
n7http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n14http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n4http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F61988987%3A17110%2F02%3AA1000VRW%21RIV10-MSM-17110___/
n8http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n15http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n5http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n13http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n17http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F61988987%3A17110%2F02%3AA1000VRW%21RIV10-MSM-17110___
rdf:type
skos:Concept n14:Vysledek
dcterms:description
The objective of the investigation is evaluation of therapeutic results and the development of the prognosis of patients with multiple myeloma (MM) as a result of consecutive changes of therapeutic procedures in patients of central and northern Moravia in the course of the last 40 years. Methods and results: Conclusion: From the submitted analysis ensured that during the period form 1959 - 2000 in patients with mutiple myeloma in central and northern Moravia as a result of the application of modern methods of chemotheraphy and supporting treatment a significant improvements of results of conventional treatment occurred with a more than 5 fold prolongation of so far assessable median values of survival (8 - 44 months) and long-term 10-year survival of almost one sixth of the patients. The real asset of %22HD%22 theraphy with transplantation of ASCT will be revealed by analyses made after a longer time interval. The objective of the investigation is evaluation of therapeutic results and the development of the prognosis of patients with multiple myeloma (MM) as a result of consecutive changes of therapeutic procedures in patients of central and northern Moravia in the course of the last 40 years. Methods and results: Conclusion: From the submitted analysis ensured that during the period form 1959 - 2000 in patients with mutiple myeloma in central and northern Moravia as a result of the application of modern methods of chemotheraphy and supporting treatment a significant improvements of results of conventional treatment occurred with a more than 5 fold prolongation of so far assessable median values of survival (8 - 44 months) and long-term 10-year survival of almost one sixth of the patients. The real asset of %22HD%22 theraphy with transplantation of ASCT will be revealed by analyses made after a longer time interval.
dcterms:title
Therapeutic results and changes in prognosis in patients with multiple myeloma in central and northern Moravia over the past 40 years Therapeutic results and changes in prognosis in patients with multiple myeloma in central and northern Moravia over the past 40 years
skos:prefLabel
Therapeutic results and changes in prognosis in patients with multiple myeloma in central and northern Moravia over the past 40 years Therapeutic results and changes in prognosis in patients with multiple myeloma in central and northern Moravia over the past 40 years
skos:notation
RIV/61988987:17110/02:A1000VRW!RIV10-MSM-17110___
n3:aktivita
n15:S
n3:aktivity
S
n3:cisloPeriodika
8
n3:dodaniDat
n17:2010
n3:domaciTvurceVysledku
n7:3867781 n7:1383914
n3:druhVysledku
n13:J
n3:duvernostUdaju
n8:S
n3:entitaPredkladatele
n4:predkladatel
n3:idSjednocenehoVysledku
666878
n3:idVysledku
RIV/61988987:17110/02:A1000VRW
n3:jazykVysledku
n5:eng
n3:klicovaSlova
antineoplastic agen
n3:klicoveSlovo
n10:antineoplastic%20agen
n3:kodStatuVydavatele
CZ - Česká republika
n3:kontrolniKodProRIV
[976B715E4292]
n3:nazevZdroje
Vnitřní lékařství
n3:obor
n12:FE
n3:pocetDomacichTvurcuVysledku
2
n3:pocetTvurcuVysledku
2
n3:rokUplatneniVysledku
n17:2002
n3:svazekPeriodika
48
n3:tvurceVysledku
Gumulec, Jaromír Martínek, Arnošt
s:issn
0042-773X
s:numberOfPages
11
n16:organizacniJednotka
17110